Author:
Jonathan Tinotenda Chanyandura,Norman Zimunda Nyazema
Subject
Pharmaceutical Science,Pharmacology
Reference10 articles.
1. Banach M, Patti AM, Giglio RV, Cicero AFG, Bajraktari G, Brucker E, Descamps O, Djuric D, Ezhov M, Fras Z, von Haehling S (2018). The role of nutraceuticals in statin intolerant patients. Journal of the America College of Cardiology 72(1):96-118
2. Food and Drug Administration (FDA) (2016). Labeling and Nutrition. Food and Drug Administration, US Department of Health and Human Services. 5 October 2016. Retrieved 21 Nov 2020
3. Gupta S, Yadav AK (2022). Emerging trend of chondroitin sulfate in nanoparticles preparation, targeting, and pharmaceutical applications. Polysaccharide Nanoparticles pp. 65-90.
4. Kaplan S (2019). Supplement makers touting cures for Alzheimers and other diseases get FDA warning. New York Times, 11 February 2019. Retrieved 21 Nov 2020
5. Lockwood GB (2015). Quality evaluation and safety of commercially available nutraceutical and formulated products. In: Nutraceutical and Functional Processing Technology (pp. 113-150).